HEADER CYTOKINE 10-NOV-20 7KPA TITLE ASYMMETRIC HTNF-ALPHA COMPND MOL_ID: 1; COMPND 2 MOLECULE: TUMOR NECROSIS FACTOR; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: CACHECTIN,TNF-ALPHA,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY COMPND 5 MEMBER 2,TNF-A; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TNF, TNFA, TNFSF2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: TOP10; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PEMB54 KEYWDS TNF, RECEPTOR, TNFR1, SYMMETRIC, CYTOKINE EXPDTA X-RAY DIFFRACTION AUTHOR D.FOX III,C.M.LUKACS,T.CESKA REVDAT 4 03-APR-24 7KPA 1 REMARK REVDAT 3 29-JUN-22 7KPA 1 TITLE JRNL REVDAT 2 03-FEB-21 7KPA 1 JRNL REVDAT 1 13-JAN-21 7KPA 0 JRNL AUTH D.J.LIGHTWOOD,R.J.MUNRO,J.PORTER,D.MCMILLAN,B.CARRINGTON, JRNL AUTH 2 A.TURNER,A.SCOTT-TUCKER,E.S.HICKFORD,A.SCHMIDT,D.FOX III, JRNL AUTH 3 A.MALONEY,T.CESKA,T.BOURNE,J.O'CONNELL,A.D.G.LAWSON JRNL TITL A CONFORMATION-SELECTIVE MONOCLONAL ANTIBODY AGAINST A SMALL JRNL TITL 2 MOLECULE-STABILISED SIGNALLING-DEFICIENT FORM OF TNF. JRNL REF NAT COMMUN V. 12 583 2021 JRNL REFN ESSN 2041-1723 JRNL PMID 33495445 JRNL DOI 10.1038/S41467-020-20825-6 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.13_2998) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.03 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 3 NUMBER OF REFLECTIONS : 18965 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.221 REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1897 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 27.0300 - 5.5287 0.93 1253 139 0.1886 0.2179 REMARK 3 2 5.5287 - 4.3944 0.96 1236 137 0.1600 0.1988 REMARK 3 3 4.3944 - 3.8407 0.97 1220 137 0.1692 0.1912 REMARK 3 4 3.8407 - 3.4903 0.96 1206 134 0.2079 0.2623 REMARK 3 5 3.4903 - 3.2406 0.98 1211 134 0.2316 0.2774 REMARK 3 6 3.2406 - 3.0498 0.98 1229 136 0.2398 0.2984 REMARK 3 7 3.0498 - 2.8973 0.99 1205 134 0.2524 0.3119 REMARK 3 8 2.8973 - 2.7713 0.99 1215 135 0.2575 0.3388 REMARK 3 9 2.7713 - 2.6647 0.99 1227 136 0.2566 0.2936 REMARK 3 10 2.6647 - 2.5728 0.99 1219 135 0.2552 0.3141 REMARK 3 11 2.5728 - 2.4924 1.00 1213 135 0.2594 0.3118 REMARK 3 12 2.4924 - 2.4212 1.00 1216 136 0.2664 0.2927 REMARK 3 13 2.4212 - 2.3575 1.00 1230 137 0.2619 0.3482 REMARK 3 14 2.3575 - 2.3000 0.99 1188 132 0.2737 0.3269 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.310 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.160 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 36.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.69 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 3295 REMARK 3 ANGLE : 1.075 4517 REMARK 3 CHIRALITY : 0.063 519 REMARK 3 PLANARITY : 0.006 585 REMARK 3 DIHEDRAL : 13.171 1945 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7KPA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-NOV-20. REMARK 100 THE DEPOSITION ID IS D_1000252855. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-JUL-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-G REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9786 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18973 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 5.530 REMARK 200 R MERGE (I) : 0.11700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.7700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.36 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.67400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: UNPUBLISHED STRUCTURE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 24.4% PEG 3350, 100 MM HEPES, PH7.0, REMARK 280 VAPOR DIFFUSION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.56500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 46.52000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.06500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 46.52000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.56500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.06500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5360 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17800 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -29.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 0 REMARK 465 VAL A 1 REMARK 465 ARG A 2 REMARK 465 SER A 3 REMARK 465 SER A 4 REMARK 465 SER A 5 REMARK 465 GLU A 107 REMARK 465 GLY A 108 REMARK 465 ALA A 109 REMARK 465 GLU A 110 REMARK 465 ALA A 111 REMARK 465 SER B 0 REMARK 465 VAL B 1 REMARK 465 ARG B 2 REMARK 465 SER B 3 REMARK 465 SER B 4 REMARK 465 SER B 5 REMARK 465 ARG B 6 REMARK 465 PRO B 106 REMARK 465 GLU B 107 REMARK 465 GLY B 108 REMARK 465 ALA B 109 REMARK 465 GLU B 110 REMARK 465 SER C 0 REMARK 465 VAL C 1 REMARK 465 ARG C 2 REMARK 465 SER C 3 REMARK 465 SER C 4 REMARK 465 SER C 5 REMARK 465 ARG C 6 REMARK 465 THR C 7 REMARK 465 PRO C 8 REMARK 465 PRO C 20 REMARK 465 GLN C 21 REMARK 465 ARG C 32 REMARK 465 ALA C 33 REMARK 465 SER C 86 REMARK 465 TYR C 87 REMARK 465 GLN C 88 REMARK 465 GLN C 102 REMARK 465 ARG C 103 REMARK 465 GLU C 104 REMARK 465 THR C 105 REMARK 465 PRO C 106 REMARK 465 GLU C 107 REMARK 465 GLY C 108 REMARK 465 ALA C 109 REMARK 465 GLU C 110 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 6 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 65 CG CD CE NZ REMARK 470 SER A 71 OG REMARK 470 THR A 72 OG1 CG2 REMARK 470 LEU A 75 CG CD1 CD2 REMARK 470 GLN A 102 CG CD OE1 NE2 REMARK 470 ARG A 103 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 104 CG CD OE1 OE2 REMARK 470 LYS A 112 CG CD CE NZ REMARK 470 LYS A 128 CG CD CE NZ REMARK 470 GLU A 146 CG CD OE1 OE2 REMARK 470 THR B 7 OG1 CG2 REMARK 470 GLU B 23 CG CD OE1 OE2 REMARK 470 ARG B 44 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 65 CG CD CE NZ REMARK 470 GLN B 67 CG CD OE1 NE2 REMARK 470 THR B 72 OG1 CG2 REMARK 470 HIS B 73 CG ND1 CD2 CE1 NE2 REMARK 470 ARG B 103 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 104 CG CD OE1 OE2 REMARK 470 THR B 105 OG1 CG2 REMARK 470 LYS B 112 CG CD CE NZ REMARK 470 LYS B 128 CG CD CE NZ REMARK 470 ASP C 10 CG OD1 OD2 REMARK 470 LYS C 11 CG CD CE NZ REMARK 470 GLU C 23 CG CD OE1 OE2 REMARK 470 GLN C 25 CG CD OE1 NE2 REMARK 470 GLN C 27 CG CD OE1 NE2 REMARK 470 ARG C 31 CG CD NE CZ NH1 NH2 REMARK 470 ASN C 34 CG OD1 ND2 REMARK 470 LEU C 36 CG CD1 CD2 REMARK 470 GLU C 42 CG CD OE1 OE2 REMARK 470 ARG C 44 CG CD NE CZ NH1 NH2 REMARK 470 VAL C 49 CG1 CG2 REMARK 470 LYS C 65 CG CD CE NZ REMARK 470 GLN C 67 CG CD OE1 NE2 REMARK 470 SER C 71 OG REMARK 470 THR C 72 OG1 CG2 REMARK 470 VAL C 74 CG1 CG2 REMARK 470 VAL C 85 CG1 CG2 REMARK 470 THR C 89 OG1 CG2 REMARK 470 LYS C 112 CG CD CE NZ REMARK 470 ARG C 131 CG CD NE CZ NH1 NH2 REMARK 470 PHE C 144 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU C 146 CG CD OE1 OE2 REMARK 470 SER C 147 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 201 O HOH B 221 1.88 REMARK 500 O GLY B 40 O HOH B 201 2.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 36 CA - CB - CG ANGL. DEV. = 19.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 22 65.58 -103.12 REMARK 500 TYR A 87 76.68 -157.76 REMARK 500 LEU C 37 82.78 -176.29 REMARK 500 SER C 52 135.73 -170.38 REMARK 500 PHE C 144 30.34 -141.89 REMARK 500 REMARK 500 REMARK: NULL DBREF 7KPA A 1 157 UNP P01375 TNFA_HUMAN 77 233 DBREF 7KPA B 1 157 UNP P01375 TNFA_HUMAN 77 233 DBREF 7KPA C 1 157 UNP P01375 TNFA_HUMAN 77 233 SEQADV 7KPA SER A 0 UNP P01375 EXPRESSION TAG SEQADV 7KPA SER B 0 UNP P01375 EXPRESSION TAG SEQADV 7KPA SER C 0 UNP P01375 EXPRESSION TAG SEQRES 1 A 158 SER VAL ARG SER SER SER ARG THR PRO SER ASP LYS PRO SEQRES 2 A 158 VAL ALA HIS VAL VAL ALA ASN PRO GLN ALA GLU GLY GLN SEQRES 3 A 158 LEU GLN TRP LEU ASN ARG ARG ALA ASN ALA LEU LEU ALA SEQRES 4 A 158 ASN GLY VAL GLU LEU ARG ASP ASN GLN LEU VAL VAL PRO SEQRES 5 A 158 SER GLU GLY LEU TYR LEU ILE TYR SER GLN VAL LEU PHE SEQRES 6 A 158 LYS GLY GLN GLY CYS PRO SER THR HIS VAL LEU LEU THR SEQRES 7 A 158 HIS THR ILE SER ARG ILE ALA VAL SER TYR GLN THR LYS SEQRES 8 A 158 VAL ASN LEU LEU SER ALA ILE LYS SER PRO CYS GLN ARG SEQRES 9 A 158 GLU THR PRO GLU GLY ALA GLU ALA LYS PRO TRP TYR GLU SEQRES 10 A 158 PRO ILE TYR LEU GLY GLY VAL PHE GLN LEU GLU LYS GLY SEQRES 11 A 158 ASP ARG LEU SER ALA GLU ILE ASN ARG PRO ASP TYR LEU SEQRES 12 A 158 ASP PHE ALA GLU SER GLY GLN VAL TYR PHE GLY ILE ILE SEQRES 13 A 158 ALA LEU SEQRES 1 B 158 SER VAL ARG SER SER SER ARG THR PRO SER ASP LYS PRO SEQRES 2 B 158 VAL ALA HIS VAL VAL ALA ASN PRO GLN ALA GLU GLY GLN SEQRES 3 B 158 LEU GLN TRP LEU ASN ARG ARG ALA ASN ALA LEU LEU ALA SEQRES 4 B 158 ASN GLY VAL GLU LEU ARG ASP ASN GLN LEU VAL VAL PRO SEQRES 5 B 158 SER GLU GLY LEU TYR LEU ILE TYR SER GLN VAL LEU PHE SEQRES 6 B 158 LYS GLY GLN GLY CYS PRO SER THR HIS VAL LEU LEU THR SEQRES 7 B 158 HIS THR ILE SER ARG ILE ALA VAL SER TYR GLN THR LYS SEQRES 8 B 158 VAL ASN LEU LEU SER ALA ILE LYS SER PRO CYS GLN ARG SEQRES 9 B 158 GLU THR PRO GLU GLY ALA GLU ALA LYS PRO TRP TYR GLU SEQRES 10 B 158 PRO ILE TYR LEU GLY GLY VAL PHE GLN LEU GLU LYS GLY SEQRES 11 B 158 ASP ARG LEU SER ALA GLU ILE ASN ARG PRO ASP TYR LEU SEQRES 12 B 158 ASP PHE ALA GLU SER GLY GLN VAL TYR PHE GLY ILE ILE SEQRES 13 B 158 ALA LEU SEQRES 1 C 158 SER VAL ARG SER SER SER ARG THR PRO SER ASP LYS PRO SEQRES 2 C 158 VAL ALA HIS VAL VAL ALA ASN PRO GLN ALA GLU GLY GLN SEQRES 3 C 158 LEU GLN TRP LEU ASN ARG ARG ALA ASN ALA LEU LEU ALA SEQRES 4 C 158 ASN GLY VAL GLU LEU ARG ASP ASN GLN LEU VAL VAL PRO SEQRES 5 C 158 SER GLU GLY LEU TYR LEU ILE TYR SER GLN VAL LEU PHE SEQRES 6 C 158 LYS GLY GLN GLY CYS PRO SER THR HIS VAL LEU LEU THR SEQRES 7 C 158 HIS THR ILE SER ARG ILE ALA VAL SER TYR GLN THR LYS SEQRES 8 C 158 VAL ASN LEU LEU SER ALA ILE LYS SER PRO CYS GLN ARG SEQRES 9 C 158 GLU THR PRO GLU GLY ALA GLU ALA LYS PRO TRP TYR GLU SEQRES 10 C 158 PRO ILE TYR LEU GLY GLY VAL PHE GLN LEU GLU LYS GLY SEQRES 11 C 158 ASP ARG LEU SER ALA GLU ILE ASN ARG PRO ASP TYR LEU SEQRES 12 C 158 ASP PHE ALA GLU SER GLY GLN VAL TYR PHE GLY ILE ILE SEQRES 13 C 158 ALA LEU HET D84 C 201 41 HETNAM D84 5-(1-{[2-(DIFLUOROMETHOXY)PHENYL]METHYL}-2-{[3-(2- HETNAM 2 D84 OXOPYRROLIDIN-1-YL)PHENOXY]METHYL}-1H-BENZIMIDAZOL-6- HETNAM 3 D84 YL)PYRIDIN-2(1H)-ONE FORMUL 4 D84 C31 H26 F2 N4 O4 FORMUL 5 HOH *63(H2 O) HELIX 1 AA1 ARG B 138 LEU B 142 5 5 HELIX 2 AA2 ARG C 138 LEU C 142 5 5 HELIX 3 AA3 GLU C 146 GLN C 149 5 4 SHEET 1 AA1 5 TRP A 28 LEU A 29 0 SHEET 2 AA1 5 VAL A 13 ALA A 18 -1 N VAL A 17 O LEU A 29 SHEET 3 AA1 5 TYR A 151 ALA A 156 -1 O PHE A 152 N VAL A 16 SHEET 4 AA1 5 GLY A 54 GLN A 67 -1 N LEU A 57 O ILE A 155 SHEET 5 AA1 5 PRO A 113 TYR A 119 -1 O ILE A 118 N VAL A 62 SHEET 1 AA2 5 LEU A 36 ALA A 38 0 SHEET 2 AA2 5 VAL A 13 ALA A 18 -1 N HIS A 15 O LEU A 36 SHEET 3 AA2 5 TYR A 151 ALA A 156 -1 O PHE A 152 N VAL A 16 SHEET 4 AA2 5 GLY A 54 GLN A 67 -1 N LEU A 57 O ILE A 155 SHEET 5 AA2 5 GLY A 122 LEU A 126 -1 O LEU A 126 N GLY A 54 SHEET 1 AA3 5 GLU A 42 ARG A 44 0 SHEET 2 AA3 5 GLN A 47 VAL A 49 -1 O GLN A 47 N ARG A 44 SHEET 3 AA3 5 ARG A 131 ILE A 136 -1 O LEU A 132 N LEU A 48 SHEET 4 AA3 5 LEU A 76 ALA A 84 -1 N ILE A 83 O ARG A 131 SHEET 5 AA3 5 TYR A 87 LYS A 98 -1 O LEU A 93 N ILE A 80 SHEET 1 AA4 3 TRP B 28 LEU B 29 0 SHEET 2 AA4 3 VAL B 13 ALA B 18 -1 N VAL B 17 O LEU B 29 SHEET 3 AA4 3 LEU B 36 ALA B 38 -1 O LEU B 36 N HIS B 15 SHEET 1 AA5 5 TRP B 28 LEU B 29 0 SHEET 2 AA5 5 VAL B 13 ALA B 18 -1 N VAL B 17 O LEU B 29 SHEET 3 AA5 5 TYR B 151 ALA B 156 -1 O PHE B 152 N VAL B 16 SHEET 4 AA5 5 GLY B 54 GLN B 67 -1 N LEU B 57 O ILE B 155 SHEET 5 AA5 5 PRO B 113 LEU B 126 -1 O LEU B 120 N SER B 60 SHEET 1 AA6 5 GLU B 42 ARG B 44 0 SHEET 2 AA6 5 GLN B 47 VAL B 49 -1 O VAL B 49 N GLU B 42 SHEET 3 AA6 5 ARG B 131 ILE B 136 -1 O LEU B 132 N LEU B 48 SHEET 4 AA6 5 LEU B 76 ILE B 83 -1 N SER B 81 O SER B 133 SHEET 5 AA6 5 LYS B 90 LYS B 98 -1 O LEU B 94 N ILE B 80 SHEET 1 AA7 3 TRP C 28 ARG C 31 0 SHEET 2 AA7 3 VAL C 13 ALA C 18 -1 N VAL C 17 O LEU C 29 SHEET 3 AA7 3 ALA C 35 ALA C 38 -1 O LEU C 36 N HIS C 15 SHEET 1 AA8 5 TRP C 28 ARG C 31 0 SHEET 2 AA8 5 VAL C 13 ALA C 18 -1 N VAL C 17 O LEU C 29 SHEET 3 AA8 5 TYR C 151 ALA C 156 -1 O PHE C 152 N VAL C 16 SHEET 4 AA8 5 GLY C 54 GLN C 67 -1 N GLN C 61 O TYR C 151 SHEET 5 AA8 5 PRO C 113 LEU C 126 -1 O GLY C 122 N ILE C 58 SHEET 1 AA9 5 GLU C 42 ARG C 44 0 SHEET 2 AA9 5 GLN C 47 VAL C 49 -1 O VAL C 49 N GLU C 42 SHEET 3 AA9 5 ARG C 131 ILE C 136 -1 O LEU C 132 N LEU C 48 SHEET 4 AA9 5 LEU C 76 ILE C 83 -1 N THR C 79 O GLU C 135 SHEET 5 AA9 5 LYS C 90 LYS C 98 -1 O LYS C 98 N LEU C 76 SSBOND 1 CYS A 69 CYS A 101 1555 1555 2.04 SSBOND 2 CYS B 69 CYS B 101 1555 1555 2.05 SSBOND 3 CYS C 69 CYS C 101 1555 1555 2.05 CRYST1 55.130 82.130 93.040 90.00 90.00 90.00 P 21 21 21 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018139 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012176 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010748 0.00000